Table 2.
All published RCTs on HSG/tubal flushing with oil-based compared to water-based CM
| Author | Year | Oil-based CM | Water-based CM | Pregnancies oil | Pregnancies water | p value |
|---|---|---|---|---|---|---|
| Schwabe et al [21] | 1983 | Ethiodol* | Sinografin* | 11/56 (20%) | 7/65 (11%) | NS |
| Alper et al [16] | 1986 | Lipiodol | Diatrizoate | 14/46 (30%) | 15/60 (25%) | NS |
| Boer de et al [22] | 1988 | Ethiodol* | Iopamidol | 30/87 (34%) | 23/88 (26%) | < 0.1 |
| Rasmussen et al [17] | 1991 | Lipiodol |
Diatrizoate Ioxaglate Iohexol |
33% |
Dia: 12% Iox: 17.6% Ioh: 20.8% |
= 0.04 |
| Lindequist et al [18] | 1994 | Lipiodol | Iotrolan* | 29/121 (24%) | 24/121 (20%) | = 0.44 |
| Spring et al [23] | 2000 | Ethiodol* | Sinografin* | 53/273 (19%) | 54/260 (20%) | = 0.64 |
| Dreyer et al [11] | 2017 | Lipiodol | Telebrix hystero* | 220/554 (40%) | 161/554 (29%) | < 0.001 |
| Zhang et al [14] | 2022 | Lipiodol |
Iohexol Iopromide Ioverol* |
136/473 (29%) | 96/479 (20%) | = 0.001 |
Sinografin: A mixure of 52.7% diatrizoate meglumine and 26.8% iodipamide meglumine. Both high osmolar ionic CM
Telebrix hystero: Ioxothalamic acid meglumine, a high osmolar ionic CM
Diatrizoate: High-osmolar, ionic CM. Branded under several names
Iopamidol: Low-osmolar, non-ionic CM. Branded under several names
Ioxaglate: Low-osmolar, ionic CM. Branded as Hexabrix
Iohexol: Low-osmolar, non-ionic CM. Branded as Omnipaque
Iotrolan: Iso-osmolar, non-ionic CM. Branded as Isovis
Iopromide: Low-osmolar, non-ionic CM. Branded as Ultravist
Ioverol: Low-osmolar, non-ionic CM. Only available in China
*Not commercially available